This HTML5 document contains 101 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n8http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q114737579
rdf:type
wikibase:Item
schema:description
artículo científico publicado en 2020 artikull shkencor artykuł naukowy videnskabelig artikel udgivet 6. marts 2020 სამეცნიერო სტატია 2020年学术文章 2020年學術文章 artikel ilmiah scientific article published on 06 March 2020 artigo científico teaduslik artikkel 2020年学术文章 научна статия article científic 2020年學術文章 מאמר מדעי article scientific article scientifique articol științific artigo científico 2020 nî lūn-bûn artículu científicu espublizáu en marzu de 2020 vitskapeleg artikkel 2020年學術文章 vědecký článek wetenschappelijk artikel 2020年の論文 научни чланак ৬ মার্চ ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2020年學術文章 tieteellinen artikkeli наукова стаття, опублікована в березні 2020 мақолаи илмӣ vetenskaplig artikel vitenskapelig artikkel 2020年学术文章 naučni članak научни чланак wissenschaftlicher Artikel scientific article published on 6 March 2020 vedecký článok επιστημονικό άρθρο artikulong pang-agham tudományos cikk scienca artikolo مقالة بحثية نشرت في 6 مارس 2020 2020年学术文章 научная статья 2020年學術文章 bài báo khoa học bilimsel makale articolo scientifico artigo científico 2020年学术文章 2020年学术文章 บทความทางวิทยาศาสตร์ scientific article published on 6 March 2020 2020년 논문
p:P577
wds:Q114737579-C2E099F4-1EF0-4216-8B0D-58B2BC26A3E1
wdt:P577
2020-03-06T00:00:00Z
p:P2093
wds:Q114737579-BF5EAF84-57D5-4EBD-95B0-4A001D0CE192 wds:Q114737579-D13381C5-397F-4718-AA9F-0677459DF094 wds:Q114737579-D9414D75-918D-4A61-A7FF-B69825FAF1FF wds:Q114737579-C2446394-B449-4A80-9B0E-C2FB27D876BC wds:Q114737579-E4C734A7-8258-4702-9B8E-0333F8056CE7 wds:Q114737579-19ED51EE-E4E3-4789-B9F6-E658958B3B8B wds:Q114737579-29A560A0-81A3-4503-AAA1-6D0A1FC860F2 wds:Q114737579-769E7860-0A18-4F95-8FAA-865D11994034 wds:Q114737579-7E48CC98-8BA0-4864-A2FE-A1E7635D0137 wds:Q114737579-A91D880C-BE0D-44CA-9352-17B5DBA9BB87
wdt:P2093
T. F. Gajewski J. Sosman S. Antonia J. M. Kirkwood J. Gomez- Navarro L. H. Camacho D. Pavlov B. Redman C. Bulanhagui A. Ribas
rdfs:label
Results of a phase II clinical trial of 2 doses and schedules of CP-675,206, an anti-CTLA4 monoclonal antibody, in patients (pts) with advanced melanoma
skos:prefLabel
Results of a phase II clinical trial of 2 doses and schedules of CP-675,206, an anti-CTLA4 monoclonal antibody, in patients (pts) with advanced melanoma
schema:name
Results of a phase II clinical trial of 2 doses and schedules of CP-675,206, an anti-CTLA4 monoclonal antibody, in patients (pts) with advanced melanoma
p:P1476
wds:Q114737579-55FF2AE9-F755-40A3-AC87-ECAB28B03E9A
wdt:P1476
Results of a phase II clinical trial of 2 doses and schedules of CP-675,206, an anti-CTLA4 monoclonal antibody, in patients (pts) with advanced melanoma
p:P304
wds:Q114737579-31DE2252-3C56-4556-8981-057B8B5DA7A8
wdt:P304
3000-3000
p:P31
wds:Q114737579-5BD1E5F5-DA56-40AF-80FD-50601CA24677
wdt:P31
wd:Q13442814
p:P921
wds:Q114737579-738D55F6-D1FC-415F-80E5-18340903CB7A
wdt:P921
wd:Q42824440
p:P1433
wds:Q114737579-08632336-D3B9-470B-A3AC-1DC067EB0549
wdt:P1433
wd:Q400292
p:P433
wds:Q114737579-A4F3C9DE-CFDA-473E-8E72-5B80922901AE
p:P478
wds:Q114737579-63E676D6-DB93-44AB-BB5A-7548B2F1B617
wdt:P433
18_suppl
wdt:P478
25
p:P356
wds:Q114737579-89AE41E1-7EA3-4793-AFC9-E26D12F67038
wdtn:P356
n8:JCO.2007.25.18_SUPPL.3000
wdt:P356
10.1200/JCO.2007.25.18_SUPPL.3000